Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May;17(5):4133-4138.
doi: 10.3892/ol.2018.9736. Epub 2018 Nov 19.

Acanthosis nigricans: To be or not to be afraid

Affiliations
Review

Acanthosis nigricans: To be or not to be afraid

Maria-Linda Popa et al. Oncol Lett. 2019 May.

Abstract

Acanthosis nigricans (AN), a skin disorder with high prevalence, represents a dermatological condition with esthetic implications, but otherwise mild symptoms. For any clinician, it is in fact the tip of the iceberg, leading him/her to investigate what lies beneath the surface, since AN points to a systemic problem or disease: metabolic disorder (most frequently), endocrine syndrome, medication side effects, malignancy, and genetic factors. Sometimes, it is the first observed sign of a malignancy or of diabetes mellitus, especially in patients with chronic metabolic disorder; therefore, it is not to be taken lightly. The present review summarizes the information in literature regarding the etiopathogenesis of AN. We propose a new classification that aims to better organize the different types of AN, with implications on the extent and urgency of the investigation plan, as well as various therapeutic algorithms. Therapy options are also presented, both systemic treatments that target the underlying disease, and local ones for esthetic reasons.

Keywords: acanthosis nigricans; differential diagnosis; endocrine disorders; hyperpigmentation; insulin resistance; paraneoplastic syndrome.

PubMed Disclaimer

References

    1. Quatrano NA, Loechner KJ. Dermatologic manifestations of endocrine disorders. Curr Opin Pediatr. 2012;24:487–493. doi: 10.1097/MOP.0b013e328355a31b. - DOI - PubMed
    1. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5:239–249. doi: 10.4103/2229-5178.137765. - DOI - PMC - PubMed
    1. Gómez-Flores M, González-Saldivar G, Santos-Santos O, Álvarez-Villalobos N, Rodríguez-Gutiérrez R, Tellez-Hinojosa C, González-González J. Implications of a clinically ignored site of acanthosis nigricans: The knuckles. Exp Clin Endocrinol Diabetes. 2015;123:27–33. - PubMed
    1. Schnopp C, Baumstark J. Images in clinical medicine. Oral acanthosis nigricans. N Engl J Med. 2007;357:e10. doi: 10.1056/NEJMicm062917. - DOI - PubMed
    1. Judge MR, McLean WH, Munro C. Disorders of keratinization. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th. Blackwell Publishing; Oxford: 2010. pp. 119–121.